ARWEN

We at ARWEN are delighted to see new discoveries in the field of cancer research, particularly those highlighting the significant potential of preventative measures. The recent study from the American Cancer Society underscores the crucial role that modifiable risk factors play in cancer prevention, revealing that nearly 50% of cancer-related deaths in the US could be prevented through healthier lifestyle choices and improved access to healthcare. This study's findings emphasise the importance of broad and equitable implementation of preventative initiatives, such as promoting smoking cessation, maintaining a healthy body weight, and increasing vaccination rates against cancer-related viruses. These measures can significantly reduce the number of cancer cases and deaths, highlighting the need for increased awareness and access to preventative healthcare. Real-world data is invaluable in this context because it reflects the complexities and variances of patients' lives outside controlled clinical trials. Unlike in clinical trials, where factors such as smoking, sun exposure, and diet are often controlled or factored out, real-world data encompasses the diverse lifestyles and environments of real patients. This makes it highly relevant for determining not only the best care paths but also effective prevention tactics. Read more at: https://lnkd.in/eRfq4QnC

Our latest newsletter focuses on improving healthcare through real-world evidence. Learn how to innovative data solutions are transforming patient care and outcomes. #Healthcare #Innovation #RealWorldEvidence

Our colleague Nadieh Kuijpers is representing ARWEN at the IFPA Conference in Stockholm, Sweden. Today marks her second and final day at this esteemed event, so there’s still a chance to connect with her if you’re attending! Over the past two days, Nadieh has gained invaluable insights into the latest clinical research in dermatology and rheumatology. She’s shared ARWEN’s mission of improving patient treatment through actionable real-world evidence and has been engaging in meaningful discussions with healthcare professionals and industry experts. Don’t miss this opportunity to meet Nadieh and discuss how ARWEN can support your healthcare initiatives. Let’s continue to drive innovation and enhance patient care together! #IFPA2024 #PsoriaticDisease #HealthcareInnovation #RealWorldEvidence #ARWEN #PatientCare #MedicalResearch

Today on June 25th, we join the global community in recognising World Vitiligo Day. Vitiligo is a skin condition that affects millions worldwide, causing loss of skin color in patches, which can significantly impact self-esteem and quality of life for those living with it. At ARWEN, we’re dedicated to understanding and supporting patients with autoimmune skin diseases. For instance, by setting up real-world data observatories that explore the diverse treatments used across different countries, from topical therapies to systemic interventions. By analysing international hospital data, we aim to uncover variations in treatment approaches, their efficacy, and the associated costs.     Join us on our goal to improve care pathways and innovate treatments to enhance outcomes for patients suffering from skin diseases worldwide.  #WorldVitiligoDay #ARWEN #Realworlddataimmunology #Vitiligoawareness #RWDVitiligo #Realworldevidencevitiligo

We're excited to share the latest breakthrough from the DMA (Dutch Medication Audit) project, supported by DICA (Dutch Institute for Clinical Auditing), Nederlandse Vereniging van Ziekenhuisapothekers (NVZA), and Zorgverzekeraars Nederland! With the collaboration of 56 hospitals, DMA investigated whether proton pump inhibitors (PPIs) affect the effectiveness of CKD4/6 inhibitors in breast cancer treatment. The findings? No impact on overall survival was observed, putting into question the validity of concerns about reduced efficacy when PPIs are prescribed alongside CKD4/6 inhibitors. This milestone underscores the power of data sharing and collaborative discussions in advancing patient care, which are supported by MRDM and LOGEX with data processing and analysis. 📊✨ Together, we’re transforming real-world data into real-world solutions. Join us in our mission to enhance healthcare through evidence-based insights! 👉 Learn more about our work and how you can get involved: https://lnkd.in/eH6mZd5k #HealthcareInnovation #HealthcareAnalytics #DataDrivenCare #PatientCare #ClinicalInsights #Oncology #DataAnalytics

Recent research has revealed that modern surrogate criteria, such as progression-free survival (PFS), used in evaluating innovative oncology medicines, are not accurate predictors of overall survival (OS). Read how we think real-world evidence (RWE) can address this critical issue in our latest blog. Read the full blog on our website: https://lnkd.in/dWP6ZA8X #Oncology #CancerResearch #RealWorldEvidence #SurrogateEndpoints #OverallSurvival #HealthcareInnovation #Pharma #MedicalResearch

We are very excited that the 7th World Psoriasis & Psoriatic Arthritis Conference (also known as the IFPA Conference) is almost here, a whole three years after the 6th edition. The conference comes at a perfect time, as we expand and learn from our European Psoriasis Observatory, in which hospitals across Western Europe share their psoriasis diagnostics, treatment and outcome data with the goal of closing the existing knowledge gaps around effective psoriasis treatment. Representing ARWEN at this conference will be Nadieh Kuijpers. She will be there on June 27th and 28th. Are you also there and interested to speak to her about the Psoriasis Observatory? Please do reach out to her via [email protected] to set up a meeting. #ARWEN #RealWorldEvidence #RealWorldData #RWE #RWD #IFPA2024 #HealthcareInnovation #psorariasis #psoriasisobservatory

Our latest blog, “The Role of Real-World Evidence in Oncology” is now live on our website. Dive into the evolving landscape of oncology treatment, explore current challenges, and discover how real-world evidence has the potential of bridging crucial knowledge gaps. Read the full article here: https://lnkd.in/dMnUgBj8 #Oncology #RealWorldEvidence #HealthcareInsights

We are pleased to introduce to you our Psoriasis Observatory, an initiative committed to enhancing care and treatment options for psoriasis patients. The participants can gain real-world insights into diagnostics, care pathways, treatment effectiveness, and more. Interested in learning more? Please visit the website of our initiative: https://arwen.eu/sponsor/ #Psoriasiscare #RWE #RealWorldEvidence

Our colleagues Jan van der Eijk and Renée de Valk had a good experience at #EAU24 Congress in Paris. From exploring innovative techniques to networking with global professionals, they've gained some important insights into the world of urology. We are looking forward to next year's edition already! #EAU24 #UrologyInnovation #MedicalAdvancements